Author(s):
Vinay R. Kothawade, Yashpal M. More, Pallavi P. Ahire
Email(s):
kothawadevinay@gmail.com
DOI:
10.52711/0975-4377.2024.00048 
Address:
Vinay R. Kothawade, Yashpal M. More, Pallavi P. Ahire
Loknete, Dr. J. D. Pawar, College of Pharmacy, Manur, Kalwan, Tal. Kalwan, Dist. Nashik-423501, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 4,
Year - 2024
ABSTRACT:
Bisoprolol is a type of antihypertensive drug (ß-blocker). It is a poorly water-soluble and highly permeable drug that belongs to class II biopharmaceutical classification. This investigation represents the formulation development of bisoprolol to immediate and sustained the drug release. In immediate release different types of polymers like Sodium Starch Glycolate, Crospovidone and Lactose were used in this study. In sustained release different types of polymers like HPMC, Guar Gum and Magnesium Stearate were used in this study. Eight different formulations were developed by using different excipients at various ratios. The powder blend was evaluated for bulk density, tapped density, flow property whereas tablets were evaluated for thickness, hardness, weight variation, compressibility index, uniformity of content, disintegration time, and drug release profile. The present study concluded that bilayer tablets of Bisoprolol Fumarate as an alternative to the conventional dosage form.
Cite this article:
Vinay R. Kothawade, Yashpal M. More, Pallavi P. Ahire. Development and Evaluation of Bilayer Tablets of Bimodal release of Bisoprolol Fumarate. Research Journal of Pharmaceutical Dosage Forms and Technology. 2024; 16(4):309-6. doi: 10.52711/0975-4377.2024.00048
Cite(Electronic):
Vinay R. Kothawade, Yashpal M. More, Pallavi P. Ahire. Development and Evaluation of Bilayer Tablets of Bimodal release of Bisoprolol Fumarate. Research Journal of Pharmaceutical Dosage Forms and Technology. 2024; 16(4):309-6. doi: 10.52711/0975-4377.2024.00048 Available on: https://rjpdft.com/AbstractView.aspx?PID=2024-16-4-2
REFERENCE:
1. Heba AF and Alaa AR: Effect of different and binder types on the preparation of bisoprolol fumarate as tablet dosage form. Iraqi J Pharm Sci. 2013; 22(1): 32-39
2. Kedia R, Kulkarni S, Ross M, Shivaswamy V. Spotlight on empagliflozin/metformin fixed-dose combination for the treatment of type 2 diabetes: a systematic review. Patient Preference and Adherence. 2016 Sep 30:1999-2006.
3. Parashar TA, Singh NA. Formulation and in vitro evaluation of bilayer tablet of atenolol for biphasic drug release. Asian Journal of Pharmaceutical and Clinical Research. 2018 May;11(5):114-9.
4. Chauhan D, Kaushik D. Bilayer Tablet Tendered Immediate Release of Paracetamol and Sustained Release of Ibuprofen for Quick Onset of Action Against Pain and Fever. Asian journal of Pharmaceutical and Clinical Research. 2019: 166-174
5. Pattanayak DP, Dinda SC. Bilayer tablet formulation of metformin hydrochloride and glimepiride: A novel approach to improve therapeutic efficacy. Int. J. Drug Discov. Herb. Res. 2011 Jan; 1:1-4.
6. Dey S, Chattopadhyay S, Mazumder B. Formulation and evaluation of fixed- dose combination of bilayer gastro retentive matrix tablet containing atorvastatin as fast-release and atenolol as sustained-release. BioMed Research International. 2014 Jan 2;2014
7. United States Pharmacopeial Convention, Inc: Metformin hydrochloride extended-release tablets; U.S. pharmacopoeia-national formulary [USP43NF38]. United States Pharmacopeial Convention, Inc, USA2019: 2824.
8. Guideline II. Guidance for Industry, Pharmaceutical Development Q8 (R2). In International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Silver Spring, MD: ICH 2009.
9. Gangane PS, Kadam MM, Mahapatra DK, Mahajan NM, Mahajan UN. Design and formulating gliclazide solid dispersion immediate release layer and metformin sustained release layer in bilayer tablet for the effective postprandial management of diabetes mellitus. Int J Pharm Sci Res. 2018 Sep 1;9(9):3743- 56.
10. Nivetha N. Formulation and Evaluation of Bilayer Tablet of Sustained Release Pregabalin and Immediate Release Methyl cobalamin (Doctoral dissertation, CL Baid Metha College of Pharmacy, Chennai).
11. Jat RK, Chatterjee S. Formulation and evaluation of immediate release tablet dosage form of linagliptin and metformin hydrochloride. Journal of Drug Delivery and Therapeutics. 2021 Jun 15; 11(3-S): 61-4.
12. Kumari MS, Babu MK, Rajesh K, Jyothsna G, Reddy GJ. Formulation development of metformin Hcl and repaglinide bilayer tablets: A novel approach to improve therapeutic efficacy. Research Journal of Pharmacy and Technology. 2018; 11(9): 4119-25.
13. Kumari MS, Babu MK, Rajesh K, Jyothsna G, Reddy GJ. Formulation development of metformin HCl and repaglinide bilayer tablets: A novel approach to improve therapeutic efficacy. Research Journal of Pharmacy and Technology. 2018; 11(9): 4119-25.
14. Patil MB, Maru AD, Bhadane JS. Formulation and Evaluation of Sustained Release Bilayer Matrix Tablet of Glimepiride and Metformin Hydrochloride.